Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

Innovotech Inc. Reports Record Revenue For Its Third Quarter.

By The Northwire Desk — AI Analysis Nov 04, 2025 · 17:50 IOT · 0.23 Innovotech Inc.
IOT · Price

Executive Summary

  • Innovotech Inc. reported record Q3‑2025 revenues of $1,267,692, up from prior periods, and generated a net income of $92,945.
  • Year‑to‑date (YTD) revenue reached $3,410,204, driven by strong demand for antimicrobial contract research, analytical services via Keystone Labs, and increased product sales.
  • CEO Craig Milne highlighted ongoing investments and parallel growth initiatives supporting the company’s expansion strategy.

Key Details

  • Q3‑2025 Revenue: $1,267,692 (record level).
  • Q3‑2025 Net Income: $92,945.
  • YTD Revenue (through Q3): $3,410,204.
  • Revenue Drivers:
  • Growing demand for antimicrobial contract research services.
  • Strong performance of analytical services from wholly‑owned subsidiary Keystone Labs.
  • Increased sales of proprietary antimicrobial silver solutions and related products.
  • Strategic Commentary: CEO Craig Milne stated the company is “building a foundation for continued growth” through multiple parallel efforts and investments to support expansion.

Notable Quotes

“The Company has been building a foundation for continued growth and making multiple parallel efforts and investments to support expansion,” – Craig Milne, CEO

All boilerplate, forward‑looking statements, and company background have been omitted for brevity.

Read the original news release →

More from Innovotech Inc.

May 13, 2026 · 19:10

Innovotech Lands NRC Funding to Bolster Testing Services as Revenue Slump Drives Shares to Year Low.

Production / Operations May 12, 2026 · 16:50

Innovotech’s revenue collapse exposes client concentration flaw as transformation costs mount

Earnings Apr 14, 2026 · 18:45

Innovotech Expands U.S. Access Following Profitable FY25 Turnaround

Regulatory Mar 31, 2026 · 18:10

Innovotech Posts First Profitable Year as Stock Slides to Lows, Masking Thin Margins and Liquidity Risks

Earnings Nov 20, 2025 · 17:29

Innovotech closes $200K convertible debenture financing

Financings Oct 15, 2025 · 21:04

Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000.

Financings